The real-world efficacy and safety of anlotinib in advanced non-small cell lung cancer.

Fen WangFeng JinBoran ChengYue ZhangQing ZhouShubin Wang

Published in: Journal of cancer research and clinical oncology (2021)

This study was retrospectively registered with ISRCTN Registry (ID ISRCTN35543977) on January 26th, 2021 and Chinese Clinical Trial Register (ChiCTR2000032265) on April 4th, 2020.

Keyphrases

advanced non small cell lung cancer
clinical trial
epidermal growth factor receptor
open label
study protocol
randomized controlled trial
double blind
phase iii